Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Market price (% of par)
-
90.91%
-
Total 13F principal
-
$542,898,250
-
Principal change
-
+$26,676,752
-
Total reported market value
-
$494,915,958
-
Number of holders
-
46
-
Value change
-
+$24,259,284
-
Number of buys
-
21
-
Number of sells
-
15
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q4 2022
As of 31 Dec 2022,
IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 was held by
46 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$542,898,250
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., DeepCurrents Investment Group LLC, Opti Capital Management, LP, D. E. Shaw & Co., Inc., BRAIDWELL LP, AVIVA PLC, Verition Fund Management LLC, CITADEL ADVISORS LLC, Sonora Investment Management Group, LLC, and BlackRock Inc..
This page lists
46
institutional bondholders reporting positions
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.